InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: balamidas post# 63760

Monday, 02/13/2017 9:43:26 AM

Monday, February 13, 2017 9:43:26 AM

Post# of 144814
PharmaCyte’s management, Dr. Manuel Hidalgo, TD2 and TD2’s consulting statistician are actively working to finalize the number of patients that will be included in the trial. This is the final element and will complete the adjustments necessary for a newly designed trial.

https://finance.yahoo.com/news/pharmacyte-biotech-moves-closer-filing-140000370.html

Sounds like they are very close!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News